Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, looks back on the first year of OneOncology and discusses what's to come in the next year.
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, looks back on the first year of OneOncology and discusses what's to come in the next year.
Transcript
Looking back on the first year of OneOncology, how has the partnership impacted both providers and patients?
The first year of OneOncology has been a tremendous growth opportunity for us as we’ve learned our core practices and we’ve learned how the patients flow and how the operations piece works, so we’ve now integrated a lot of the functions, particularly on the operational side so that there’s this smooth and consistent way operations are being done and the technology has been aligned.
We have the same OncoEMR system for our [electronic health record], we have the same billing system now the same revenue cycle management, enterprise management. So that now is standardized and we’re now focusing on the clinical piece, and we’ve spent a lot of time over the last 6 months figuring out where the pressure points are on our clinical enterprise and how we bring the practices together.
One of the things that’s been amazing to be is there’s so much excitement and so much expertise that varies from our practices and bringing all that together elevates all of our practices. So, we’re working now on pathways and we hope to hope a unified pathway component going forward into 2020. We’re very excited about a research network that we’ve heard from all of our partners is really important so that we can improve clinical access to clinical trials and to have more trials participate. There’s so many great drugs being evaluated now, we just need more access and we’re hearing from our manufacturers, we’re hearing from our practices, we’re hearing from patients, “Give us more opportunities,” so that’s a high priority for us in the next year as we move forward.
We’re working on a whole number of quality and value initiatives and each of these are a committee that we formed as part of our overarching leadership council called OneCouncil. Soo, we’ve established the operational piece now in the first year and moving full force into the clinical piece.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More